Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01142427 · ClinicalTrials.gov registry record
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 17,463
- Enrollment target
NCT01142427 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 17,463 participants.
The verdict
NCT01142427 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 17,463 participants
- Enrollment target
Study Summary
This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Cytology Specimen Collection Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,463 participants |
| Start Date | 2010-08-09 |
| Est. Completion | 2023-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01142427
The ClinicalTrials.gov registry entry for NCT01142427 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17,463 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01142427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01142427 about?
NCT01142427 is a clinical study titled "Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia". This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
What is the current status of trial NCT01142427?
This trial is currently completed. The enrollment target is 17,463 participants. The study started on 2010-08-09. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT01142427?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT01142427?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.